Transcutaneous Analyte Measuring Methods (TAMM Phase 2).
Abstract
The major objective of the third quarter of the project, the completion and delivery of the two BI-800 Array Analyzers, was accomplished. Both spectrometers were delivered on June 1, one to the Naval Medical Research and Development Command in Bethesda, Maryland, and the second to the Medical College of Wisconsin (Froedtert Lutheran Memorial Hospital). Clinical testing using the BI-800 systems is scheduled to begin in June (22nd) in Bethesda and by July 15th in Milwaukee. A significant effort has been devoted to developing operational procedures for TAMM/800. These procedures were developed at two levels: 1. The test sequence level Measurements to be performed at various body locations and reference standards 2. The Instrument operation level The procedures for instrument operation Both kinds of procedures are reviewed in this quarterly report. Another important area of project activity currently is analytical data reduction. An integrated set of software programs is being developed to analyze the data generated in clinical trials. These programs will allow for the development of algorithms for analyte. concentration estimations and the evaluation of their accuracy and tracking capability. This report also provides detail on this software development.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 1992
- Accession Number
- ADA252554
Entities
People
- Kenneth J. Schlager